Houkea Bunions Correction Patch
NDC Package 84660-084-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Houkea Bunions Correction Patch is a medication used as Relieves bunions by preventing joint flexion; dissolves fluid accumulation in joints and restores toe health; repairs tissue and restores toe mobility. Marketed by Guangdong Ximonth Technology Co., Ltd., this product is identified by NDC 84660-084 and is authorized under FDA application M014.

Identification & Billing

NDC Package Code
84660-084-01
Package Description
10 g in 1 BOX
Product Code
11-Digit Billing Format
84660008401

Clinical Specifications

Proprietary Name
Houkea Bunions Correction Patch
Dosage Form
-
Usage Information
This product is used as Relieves bunions by preventing joint flexion; dissolves fluid accumulation in joints and restores toe health; repairs tissue and restores toe mobility

Regulatory & Marketing

Labeler Name
Guangdong Ximonth Technology Co., Ltd.
FDA Application #
M014
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
10-23-2024
Listing Expiration
12-31-2025
Exclude Flag
I
Sample Package
No

Hierarchy Structure

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 84660-084-01 identifies a specific commercial package of 10 g in 1 box of Houkea Bunions Correction Patch, labeled by Guangdong Ximonth Technology Co., Ltd.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Guangdong Ximonth Technology Co., Ltd. on October 23, 2024. The current certification is valid through December 31, 2025.

How is this Guangdong Ximonth Technology Co., Ltd. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 84660008401. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
84660-084-01
11-Digit CMS (5-4-2)
84660-0084-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.